Indeed, two injections of 4-1BB or CD27 costimulated NKG2D CAR T cells exhibited in vivo anti-tumor effects in a highly invasive MDA-MB-231 xenograft model of human TNBC, compared to the first-generation NKG2D CAR T cells. The gene discussed is CD27; the disease is neoplasm.